viqualine
≈ 1 min read
Names in other languages
- Englishviqualine
- Portuguêsviqualina
- Tiếng Việtviqualine
- فارسیویکوالین
- Русскийвиквалин
- shvikvalin
- Српскиvikvalin
- 日本語ビクアリン
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Viqualine (INN; developmental code PK-5078) is an antidepressant and anxiolytic drug that was never marketed. It acts as a potent and selective serotonin releasing agent (SRA) and serotonin reuptake inhibitor (SRI) similarly to para-chloroamphetamine (PCA). In addition, viqualine displaces diazepam from the GABA A receptor and produces benzodiazepine-like effects, indicating that it is also a positive allosteric modulator of the benzodiazepine site of the GABA A receptor. The drug has mainly been researched as a potential treatment for alcoholism.
Viqualine (INN; developmental code PK-5078) is an antidepressant and anxiolytic drug that was never marketed. It acts as a potent and selective serotonin releasing agent (SRA) and serotonin reuptake inhibitor (SRI) similarly to para-chloroamphetamine (PCA). In addition, viqualine displaces diazepam from the GABA A receptor and produces benzodiazepine-like effects, indicating that it is also a positive allosteric modulator of the benzodiazepine site of the GABA A receptor. The drug has mainly been researched as a potential treatment for alcoholism.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1340893870 under CC BY-SA 4.0; modifications have been made.